№ files_lp_4_process_3_096403
File format: docx Character count: 6644 File size: 27 KB
Tabular reference source detailing validated and non-validated diagnostic algorithms for liver disease conditions and their corresponding ICD-9-CM and ICD-10-CM codes with positive predictive values and study settings.
Year: 2013–2021
Region / City: United States, Canada
Subject: Cirrhosis and liver disease coding
Document type: Supplementary table / Research data
Institution: University of Pennsylvania health system; Parkland Hospital; Outpatient hepatology clinic in Toronto
Authors: Nehra, Goldberg, Niu, Philip, Hagstrom
Target population: Patients with cirrhosis or liver disease
Validation status: Mixed validated and non-validated algorithms
Coding system: ICD-9-CM, ICD-10-CM
Conditions covered: Cirrhosis, decompensated cirrhosis, hepatitis B, hepatitis C, alcohol-related liver disease, non-alcoholic fatty liver disease, hepatocellular carcinoma, liver transplant
Data extraction method: Algorithm-based diagnosis code identification
Clinical relevance: Identification and classification of liver disease conditions for research and clinical coding purposes
Reference: Peer-reviewed studies and expert consensus statements
Supplementary notes: ICD-10-CM codes derived using GEM mapping when not directly validated
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Supplemental Tables: Inclusion and Exclusion Criteria and Baseline Characteristics by Baseline Bicarbonate Levels in Patients Hospitalized with Decompensated Heart Failure
Document type: Supplemental appendix tables and figures from a clinical study
Field: Cardiology
Medical condition: Decompensated heart failure
Study design element: Randomized controlled trial supplemental data
Intervention studied: Acetazolamide versus placebo
Population: Adult patients hospitalized with decompensated heart failure
Age criteria: ≥18 years
Inclusion criteria: Hospital admission for decompensated heart failure with signs of volume overload, prior maintenance therapy with oral loop diuretics, elevated NT-proBNP or BNP, documented LVEF
Exclusion criteria: Acute coronary syndrome, congenital heart disease requiring surgery, cardiac transplantation, ventricular assist device, severe hypotension, severe renal impairment, recent acetazolamide therapy, pregnancy or breastfeeding, current SGLT2 inhibitor use
Key biomarkers: NT-proBNP, BNP, bicarbonate (HCO3), sodium, chloride
Clinical measurements: LVEF, blood pressure, heart rate, congestion score, edema score
Comorbidities recorded: Atrial fibrillation, diabetes, hypertension
Baseline comparison groups: <22 mmol/L, 22–27 mmol/L, >27 mmol/L bicarbonate levels
Endpoints referenced: Successful decongestion and treatment effect outcomes
Therapies reported: Loop diuretics, ACE inhibitors, ARB, ARNI, beta-blockers, mineralocorticoid receptor antagonists
Devices reported: Implantable cardioverter-defibrillator (ICD), cardiac resynchronization therapy (CRT)
Alpha diversity analysis in infected decompensated cirrhosis patients
Year: 2023
Region / City: Not specified
Topic: Microbiome diversity in liver disease
Document Type: Scientific figure description
Institution: Not specified
Author: Not specified
Target Audience: Researchers and clinicians in hepatology and microbiology
Study Population: Patients with infected decompensated cirrhosis
Analysis Methods: Phylogenetic diversity (PD) whole tree, principal component analysis
Outcome: Comparison of survival and mortality during admission and follow-up
Supplementary Material: Inclusion and Exclusion Criteria, ICD-9-CM Codes, Model Fit Statistics, Assignment Accuracy Diagnostics, and Factors Associated with Suboptimal Control
Year: 2013
Region / City: Not specified
Topic: Clinical outcomes, Inclusion/Exclusion criteria, Medical statistics
Document Type: Supplementary material
Organization / Institution: Not specified
Author: Johnson ES, Bartman BA, Briesacher BA, Fleming NS, Gerhard T, Kornegay CJ, Nourjah P, Sauer B, Schumock GT, Sedrakyan A, Stürmer T, West SL, Schneeweiss S
Target Audience: Medical researchers, healthcare professionals
Period of validity: Not specified
Approval Date: Not specified
Date of changes: Not specified
Appendix A–B: ICD-9-CM, ICD-10-CM, CPT-4, HCPCS, NDC, and DRG Codes for Diagnostic and Treatment Identification
Document sections: Appendix A; Appendix B
Subject: Diagnostic and procedure coding for skull base fracture and related conditions
Classification systems: ICD-9-CM; ICD-10-CM; ICD-10-PCS; CPT-4; HCPCS; NDC; DRG
Conditions included: Skull base fracture; Facial weakness/paralysis/spasm; Loss of consciousness; Hearing loss; Tympanic membrane rupture; Vertigo/disequilibrium; Cerebrospinal fluid leak
Procedures included: Facial nerve decompression; Facial nerve repair/reanimation; Static eye procedures; Chemodenervation
Medications included: OnabotulinumtoxinA; IncobotulinumtoxinA; AbobotulinumtoxinA; RimabotulinumtoxinB; Steroids; Antivirals
Drug routes specified: Oral; IV; IM; Intra-tympanic
Purpose: Identification of admissions, inclusion and exclusion criteria, secondary outcomes, and treatments
Type of document: Medical coding reference appendix
Supplementary Tables of ICD-9-CM Codes for Identification of Pneumococcal Diseases and Prior Comorbidities in a Study Cohort
Document type: Supplementary tables
Subject: ICD-9-CM diagnostic codes for pneumococcal diseases and comorbidities
Disease categories: Invasive pneumococcal disease (IPD), non-IPD pneumococcal infections, acute otitis media (AOM), otitis media with effusion (OME), AOM complications
Classification system: International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)
Content structure: Disease type, clinical condition, ICD-9-CM code or code combinations, description
Clinical focus: Pneumococcal infections and related complications
Additional dataset: ICD-9-CM codes for prior comorbidities
Comorbidity categories: Neurological, cardiovascular, lung, liver, kidney, metabolic, immunological conditions
Purpose: Study cohort identification using diagnostic codes
Abbreviations: IPD (Invasive Pneumococcal Diseases), PNI (Pneumococcal Infections), AOM (Acute Otitis Media), OME (Otitis Media with Effusion)
Topics: etiologies Decompensated ICD-9-CM